THOMAS SPIEGEL: Open Payments
NPI 1770579666 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,108 in 47 payments from 11 companies in 2025. Trend: 2023 $326 · 2024 $852 · 2025 $1,108
Food & beverage: $1,108
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 9 | $222 |
| Insmed, Inc. | 6 | $183 |
| Shionogi Inc | 6 | $124 |
| Paratek Pharmaceuticals, Inc. | 5 | $108 |
| ViiV Healthcare Company | 4 | $107 |
| ABBVIE INC. | 5 | $100 |
| Merck Sharp & Dohme LLC | 5 | $99 |
| Melinta Therapeutics, LLC | 2 | $49 |
| La Jolla Pharmaceutical Company | 2 | $49 |
| Aimmune Therapeutics, Inc. | 2 | $47 |
Products named: Arikayce, Fetroja, NUZYRA, EMBLAVEO, CABENUVA, Rezzayo, ZERBAXA, DOVATO.
Industry payments across NC — which companies pay providers there.
